{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:23:05Z","timestamp":1794619385792,"version":"4.9.1"},"reference-count":38,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"\n OBJECTIVE<\/jats:title>\n Aneurysmal subarachnoid hemorrhage (aSAH)\u2013induced vasospasm is linked to increased inflammatory cell trafficking across a permeable blood-brain barrier (BBB). Elevations in serum levels of matrix metalloprotease 9 (MMP9), a BBB structural protein, have been implicated in the pathogenesis of vasospasm onset. Minocycline is a potent inhibitor of MMP9. The authors sought to detect an effect of minocycline on BBB permeability following aSAH.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n Patients presenting within 24 hours of symptom onset with imaging confirmed aSAH (Fisher grade 3 or 4) were randomized to high-dose (10 mg\/kg) minocycline or placebo. The primary outcome of interest was BBB permeability as quantitated by contrast signal intensity ratios in vascular regions of interest on postbleed day (PBD) 5 magnetic resonance permeability imaging. Secondary outcomes included serum MMP9 levels and radiographic and clinical evidence of vasospasm.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n A total of 11 patients were randomized to minocycline (n = 6) or control (n = 5) groups. No adverse events or complications attributable to minocycline were reported. High-dose minocycline administration was associated with significantly lower permeability indices on imaging analysis (p < 0.01). There was no significant difference with respect to serum MMP9 levels between groups, although concentrations trended upward in both cohorts. Radiographic vasospasm was noted in 6 patients (minocycline = 3, control = 3), with only 1 patient developing symptoms of clinical vasospasm in the minocycline cohort. There was no difference between cohorts with respect to Lindegaard ratios, transcranial Doppler values, or onset of vasospasm.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n Minocycline at high doses is well tolerated in the ruptured cerebral aneurysm population. Minocycline curtails breakdown of the BBB following aSAH as evidenced by lower permeability indices, though minocycline did not significantly alter serum MMP9 levels. Larger randomized clinical trials are needed to assess minocycline as a neuroprotectant against aSAH-induced vasospasm.<\/jats:p>\n \n Clinical trial registration no.: NCT04876638 (\n clinicaltrials.gov<\/jats:ext-link>\n )\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2021.6.jns211270","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:18:05Z","timestamp":1648549085000},"page":"1251-1259","source":"Crossref","is-referenced-by-count":7,"title":["Minocycline decreases blood-brain barrier permeability following aneurysmal subarachnoid hemorrhage: a randomized, double-blind, controlled trial"],"prefix":"10.3171","volume":"136","author":[{"given":"Ben A.","family":"Strickland","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Barisano","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidin","family":"Abedi","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Shiroishi","sequence":"additional","affiliation":[{"name":"Neuroradiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Cen","sequence":"additional","affiliation":[{"name":"Biostatistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Emanuel","sequence":"additional","affiliation":[{"name":"Neurology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebina","family":"Bulic","sequence":"additional","affiliation":[{"name":"Neurology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Kim-Tenser","sequence":"additional","affiliation":[{"name":"Neurology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Neurology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Giannotta","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Mack","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Russin","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery,"},{"name":"Neurorestoration Center, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Acta Neurochir","article-title":"A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture","volume":"Suppl. 2011;110(Pt 1):5-6.","author":"Dorsch N","unstructured":"Dorsch N. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Acta Neurochir Suppl. 2011;110(Pt 1):5-6."},{"issue":"6","key":"b2","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3171\/JNS.2008.109.12.1052","article-title":"Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage","volume":"109","author":"Schmidt JM","year":"2008","unstructured":"Schmidt JM, Wartenberg KE, Fernandez A, Claassen J, Rincon F, Ostapkovich ND, Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage. J Neurosurg. 2008;109(6):1052\u20131059.10.3171\/JNS.2008.109.12.105219035719"},{"issue":"6","key":"b3","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.wneu.2010.02.005","article-title":"A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology","volume":"73","author":"Al-Tamimi YZ","year":"2010","unstructured":"Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg. 2010;73(6):654\u2013667.2093415310.1016\/j.wneu.2010.02.005"},{"issue":"1","key":"b4","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3171\/JNS-07\/07\/0128","article-title":"Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage","volume":"107","author":"Iseda K","year":"2007","unstructured":"Iseda K, Ono S, Onoda K, Satoh M, Manabe H, Nishiguchi M, Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. J Neurosurg. 2007;107(1):128\u2013135.10.3171\/JNS-07\/07\/012817639882"},{"issue":"1","key":"b5","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.surneu.2009.05.027","article-title":"Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage","volume":"73","author":"Chaichana KL","year":"2010","unstructured":"Chaichana KL, Pradilla G, Huang J, Tamargo RJ. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg. 2010;73(1):22\u201341.10.1016\/j.surneu.2009.05.027"},{"issue":"3","key":"b6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3171\/jns.2007.106.3.442","article-title":"Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303","volume":"106","author":"Lin CL","year":"2007","unstructured":"Lin CL, Kwan AL, Dumont AS, Su YF, Kassell NF, Wang CJ, Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303. J Neurosurg. 2007;106(3):442\u2013448.10.3171\/jns.2007.106.3.44217367067"},{"issue":"2","key":"b7","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12028-009-9308-7","article-title":"CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage","volume":"12","author":"Provencio JJ","year":"2010","unstructured":"Provencio JJ, Fu X, Siu A, Rasmussen PA, Hazen SL, Ransohoff RM. CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage. Neurocrit Care. 2010;12(2):244\u2013251.10.1007\/s12028-009-9308-719967568"},{"issue":"2","key":"b8","series-title":"Neurocrit Care","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12028-010-9402-x","article-title":"Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database","volume":"13","author":"Tam AK","year":"2010","unstructured":"Tam AK, Ilodigwe D, Mocco J, Mayer S, Kassell N, Ruefenacht D, Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database. Neurocrit Care. 2010;13(2):182\u2013189.2059324710.1007\/s12028-010-9402-x"},{"issue":"3","key":"b9","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e59952","DOI":"10.1371\/journal.pone.0059952","article-title":"Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage","volume":"8","author":"Fischer M","year":"2013","unstructured":"Fischer M, Dietmann A, Beer R, Broessner G, Helbok R, Pfausler B, Differential regulation of matrix-metalloproteinases and their tissue inhibitors in patients with aneurysmal subarachnoid hemorrhage. PLoS One. 2013;8(3):e59952.10.1371\/journal.pone.005995223555845"},{"key":"b10","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neuroscience.2017.12.021","article-title":"Matrix metalloproteinase-9 mediates the deleterious effects of \u03b12-antiplasmin on blood-brain barrier breakdown and ischemic brain injury in experimental stroke","volume":"376","author":"Singh S","year":"2018","unstructured":"Singh S, Houng AK, Reed GL. Matrix metalloproteinase-9 mediates the deleterious effects of \u03b12-antiplasmin on blood-brain barrier breakdown and ischemic brain injury in experimental stroke. Neuroscience. 2018;376:40\u201347.10.1016\/j.neuroscience.2017.12.02129294343"},{"issue":"12","key":"b11","series-title":"Ann Clin Transl Neurol","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/acn3.492","article-title":"Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase-9 inhibition","volume":"4","author":"Vellimana AK","year":"2017","unstructured":"Vellimana AK, Zhou ML, Singh I, Aum DJ, Nelson JW, Harris GR, Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase-9 inhibition. Ann Clin Transl Neurol. 2017;4(12):865\u2013876.10.1002\/acn3.49229296615"},{"issue":"1","key":"b12","series-title":"Ann Clin Lab Sci","first-page":"14","article-title":"Potential contribution of matrix metalloproteinase-9 (MMP-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats","volume":"42","author":"Wang Z","year":"2012","unstructured":"Wang Z, Fang Q, Dang BQ, Shen XM, Shu Z, Zuo G, Potential contribution of matrix metalloproteinase-9 (MMP-9) to cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Ann Clin Lab Sci. 2012;42(1):14\u201320.22371905"},{"issue":"4","key":"b13","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3171\/jns.2004.101.4.0633","article-title":"Acute alterations in microvascular basal lamina after subarachnoid hemorrhage","volume":"101","author":"Sehba FA","year":"2004","unstructured":"Sehba FA, Mostafa G, Knopman J, Friedrich V Jr, Bederson JB. Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg. 2004;101(4):633\u2013640.1548171810.3171\/jns.2004.101.4.0633"},{"issue":"1","key":"b14","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3171\/jns.2002.96.1.0071","article-title":"Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage","volume":"96","author":"Mack WJ","year":"2002","unstructured":"Mack WJ, Mocco J, Hoh DJ, Huang J, Choudhri TF, Kreiter KT, Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;96(1):71\u201375.1179460710.3171\/jns.2002.96.1.0071"},{"issue":"3","key":"b15","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3171\/jns.2002.97.3.0537","article-title":"Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage","volume":"97","author":"Mocco J","year":"2002","unstructured":"Mocco J, Mack WJ, Kim GH, Lozier AP, Laufer I, Kreiter KT, Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;97(3):537\u2013541.10.3171\/jns.2002.97.3.053712296636"},{"issue":"6","key":"b16","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1177\/0271678X18768670","article-title":"Permeability imaging as a predictor of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"38","author":"Russin JJ","year":"2018","unstructured":"Russin JJ, Montagne A, D\u2019Amore F, He S, Shiroishi MS, Rennert RC, Permeability imaging as a predictor of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2018;38(6):973\u2013979.2961145110.1177\/0271678X18768670"},{"issue":"11","key":"b17","series-title":"Eur J Neurol","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/ene.13403","article-title":"Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study","volume":"24","author":"Chang JJ","year":"2017","unstructured":"Chang JJ, Kim-Tenser M, Emanuel BA, Jones GM, Chapple K, Alikhani A, Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study. Eur J Neurol. 2017;24(11):1384\u20131391.2892956010.1111\/ene.13403"},{"issue":"2","key":"b18","series-title":"Neuroimage","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","article-title":"FSL","volume":"62","author":"Jenkinson M","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage. 2012;62(2):782\u2013790.2197938210.1016\/j.neuroimage.2011.09.015"},{"issue":"3","key":"b19","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent","volume":"275","author":"Radbruch A","year":"2015","unstructured":"Radbruch A, Weberling LD, Kieslich PJ, Eidel O, Burth S, Kickingereder P, Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology. 2015;275(3):783\u2013791.10.1148\/radiol.201515033725848905"},{"issue":"12","key":"b20","series-title":"Invest Radiol","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/RLI.0000000000000227","article-title":"High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol","volume":"50","author":"Radbruch A","year":"2015","unstructured":"Radbruch A, Weberling LD, Kieslich PJ, Hepp J, Kickingereder P, Wick W, High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol. Invest Radiol. 2015;50(12):805\u2013810.10.1097\/RLI.000000000000022726523910"},{"issue":"Pt B","key":"b21","series-title":"Neuropharmacology","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.neuropharm.2017.10.034","article-title":"MRI measurements of blood-brain barrier function in dementia: a review of recent studies","volume":"134","author":"Raja R","year":"2018","unstructured":"Raja R, Rosenberg GA, Caprihan A. MRI measurements of blood-brain barrier function in dementia: a review of recent studies. Neuropharmacology. 2018;134(Pt B):259\u2013271.10.1016\/j.neuropharm.2017.10.03429107626"},{"issue":"3","key":"b22","series-title":"J Magn Reson Imaging","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/jmri.20669","article-title":"Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls","volume":"24","author":"Wang H","year":"2006","unstructured":"Wang H, Golob EJ, Su MY. Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls. J Magn Reson Imaging. 2006;24(3):695\u2013700.1687830910.1002\/jmri.20669"},{"issue":"1","key":"b23","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","article-title":"Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging","volume":"74","author":"Starr JM","year":"2003","unstructured":"Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 2003;74(1):70\u201376.10.1136\/jnnp.74.1.7012486269"},{"key":"b24","series-title":"Ann N Y Acad Sci","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1749-6632.2000.tb06402.x","article-title":"Contrast-enhanced MRI of white matter lesions in patients with blood-brain barrier dysfunction","volume":"903","author":"Wahlund LO","year":"2000","unstructured":"Wahlund LO, Bronge L. Contrast-enhanced MRI of white matter lesions in patients with blood-brain barrier dysfunction. Ann N Y Acad Sci. 2000;903:477\u2013481.1081854110.1111\/j.1749-6632.2000.tb06402.x"},{"issue":"1","key":"b25","series-title":"Dement Geriatr Cogn Disord","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000058326","article-title":"Increased blood-brain barrier permeability in white matter lesions of Binswanger\u2019s disease evaluated by contrast-enhanced MRI","volume":"14","author":"Hanyu H","year":"2002","unstructured":"Hanyu H, Asano T, Tanaka Y, Iwamoto T, Takasaki M, Abe K. Increased blood-brain barrier permeability in white matter lesions of Binswanger\u2019s disease evaluated by contrast-enhanced MRI. Dement Geriatr Cogn Disord. 2002;14(1):1\u20136.10.1159\/00005832612053125"},{"issue":"2","key":"b26","series-title":"Am J Physiol Heart Circ Physiol","doi-asserted-by":"publisher","first-page":"H558","DOI":"10.1152\/ajpheart.01275.2004","article-title":"Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia","volume":"289","author":"Gidday JM","year":"2005","unstructured":"Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol. 2005;289(2):H558\u2013H568.10.1152\/ajpheart.01275.200415764676"},{"issue":"5","key":"b27","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1161\/01.STR.29.5.1020","article-title":"Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size","volume":"29","author":"Romanic AM","year":"1998","unstructured":"Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke. 1998;29(5):1020\u20131030.959625310.1161\/01.STR.29.5.1020"},{"issue":"10","key":"b28","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1161\/01.STR.29.10.2189","article-title":"Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain","volume":"29","author":"Rosenberg GA","year":"1998","unstructured":"Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke. 1998;29(10):2189\u20132195.10.1161\/01.STR.29.10.21899756602"},{"issue":"9","key":"b29","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0271678X16655551","article-title":"Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers","volume":"36","author":"Rempe RG","year":"2016","unstructured":"Rempe RG, Hartz AMS, Bauer B. Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. J Cereb Blood Flow Metab. 2016;36(9):1481\u20131507.10.1177\/0271678X1665555127323783"},{"issue":"11","key":"b30","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","article-title":"Blood-brain barrier breakdown in acute and chronic cerebrovascular disease","volume":"42","author":"Yang Y","year":"2011","unstructured":"Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42(11):3323\u20133328.10.1161\/STROKEAHA.110.60825721940972"},{"issue":"19","key":"b31","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","article-title":"Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia","volume":"21","author":"Asahi M","year":"2001","unstructured":"Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001;21(19):7724\u20137732.10.1523\/JNEUROSCI.21-19-07724.200111567062"},{"issue":"9","key":"b32","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1161\/STROKEAHA.111.618215","article-title":"Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke","volume":"42","author":"Switzer JA","year":"2011","unstructured":"Switzer JA, Hess DC, Ergul A, Waller JL, Machado LS, Portik-Dobos V, Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke. 2011;42(9):2633\u20132635.10.1161\/STROKEAHA.111.618215"},{"issue":"5","key":"b33","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/00006123-200211000-00005","article-title":"Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"51","author":"McGirt MJ","year":"2002","unstructured":"McGirt MJ, Lynch JR, Blessing R, Warner DS, Friedman AH, Laskowitz DT. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;51(5):1128\u20131135.10.1097\/00006123-200211000-0000512383357"},{"key":"b34","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1016\/j.wneu.2020.10.008","article-title":"Risk factors for cerebral vasospasm in aneurysmal subarachnoid hemorrhage: a population-based study of 8346 patients","volume":"145","author":"Rumalla K","year":"2021","unstructured":"Rumalla K, Lin M, Ding L, Gaddis M, Giannotta SL, Attenello FJ, Mack WJ. Risk factors for cerebral vasospasm in aneurysmal subarachnoid hemorrhage: a population-based study of 8346 patients. World Neurosurg. 2021;145:e233\u2013e241.3304938210.1016\/j.wneu.2020.10.008"},{"issue":"4","key":"b35","series-title":"Crit Care","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/cc5958","article-title":"Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage","volume":"11","author":"Keyrouz SG","year":"2007","unstructured":"Keyrouz SG, Diringer MN. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11(4):220.10.1186\/cc595817705883"},{"issue":"1","key":"b36","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1227\/01.NEU.0000218821.34014.1B","article-title":"Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified Fisher scale","volume":"59","author":"Frontera JA","year":"2006","unstructured":"Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES Jr, Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified Fisher scale. Neurosurgery. 2006;59(1):21\u201327.10.1227\/01.NEU.0000218821.34014.1B16823296"},{"issue":"3","key":"b37","series-title":"J Neuroimmune Pharmacol","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections","volume":"15","author":"Machhi J","year":"2020","unstructured":"Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15(3):359\u2013386.3269626410.1007\/s11481-020-09944-5"},{"issue":"1","key":"b38","series-title":"Magn Reson Med","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/mrm.22005","article-title":"Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI","volume":"62","author":"Sourbron S","year":"2009","unstructured":"Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med. 2009;62(1):205\u2013217.1944943510.1002\/mrm.22005"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/136\/5\/article-p1251.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/136\/5\/article-p1251.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/136\/5\/article-p1251.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:58:03Z","timestamp":1794617883000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/136\/5\/article-p1251.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":38,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2021.6.jns211270","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}